Active Pharmaceutical Ingredient (API) manufacturing remains the backbone of the Germany Pharmaceutical CDMO Market, with the segment valued at approximately USD 2.5 billion in 2024. Manufacturing services dominate the service landscape and are projected to reach USD 4.5 billion by 2035. Meanwhile, formulation development is emerging as the fastest-growing segment, reflecting industry demand...